Field safety notices: Medion Grifols Diagnostics AG
Manufacturer registered in EUDAMED: SRN CH-MF-000024272 ; country: Switzerland
2 authority publications by one authority, from 2 Jul 2018 to 30 Apr 2020.
Latest notice: 30 Apr 2020, AEMPS, Reverse Cyte 0.8% A1, A2, B, 0
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Medion Grifols Diagnostics AG or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- Reverse Cyte 0.8% A1, A2, B, 0
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- AEMPSSpainofficial source: MDmulticard Basic Extended Phenotype, referencia 210506, AEMPS, 2018-07-02MDmulticard Basic Extended Phenotype, referencia 210506
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026